Skip to content

Levodopa and chlorpromazine combination therapy for treatment of primary dystonia

Levodopa and chlorpromazine combination therapy for treatment of primary dystonia - Levodopa and chlorpromazine combination therapy for treatment of primary dystonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056138
Enrollment
96
Registered
2024-12-01
Start date
2024-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Levodopa and chlorpromazine combination therapy for treatment of primary dystonia

Interventions

chlorpromazine group On the first day, we prescribe after breakfast, and order to continue for 2 weeks. After 2 weeks continuous tratmenta, CP 5mg after breakfast, CP 5mg aftre linch, a total of CP

Sponsors

Kumamoto Neurosurgical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cervical dystonia and blepharospasm was clinically diagnosed according to the definition by Fahn. (Fahn S.Concept and classification of dystonia. Adv Neurol 1988;50:1-8) Written informed consent was obtained.

Exclusion criteria

Exclusion criteria: All participants were examined by a single movement disorder specialist who performed general physical and neurological examinations,laboratory tests, and brain magnetic resonance imaging to exclude othe cause of dystonia, includinga birth injury anf head trauma.

Design outcomes

Primary

MeasureTime frame
A single movement disorder specialist recorded the participants clinical symptoms with a video camera to assess the objective signs. Aftere that, participants evaluated their subjective clinical signs usinga a visual analog scale (VAS)

Countries

Japan

Contacts

Public ContactNobuhiro Inoue

Kumamoto Neurosurgical Hospital Neurosurgery

ninoue@knh.co.jp09023926337

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026